Search
for
Sort by
Research 121–150 of 1000+
- Psoriatic Alopecia in a Patient With Crohn Disease: An Uncommon Manifestation of Tumor Necrosis Factor α Inhibitors
- 269 Down-regulatory role of cholecystokinin on psoriatic epidermal inflammation
- Psoriasis and psoriatic arthritis patient productivity burden in the United States
- Association of psoriasis and psoriatic arthritis with human leukocyte antigen and killer cell immunoglobulin–like receptor gene frequency: A multiethnic population study
- Oral Diseases During Systemic Psoriatic Drugs: A Review of the Literature and Case Series
- Distribution of human B-defensin 2, TNF-alpha, IL-1 alpha, IL-6 and IL-8 in psoriatic skin
- Evidence for Altered Wnt Signaling in Psoriatic Skin
- Alopecia areata in a patient with psoriatic arthritis and Crohn's disease receiving etanercept
- A Case of Steatocystoma Multiplex in a Psoriatic Patient during Treatment with Anti-IL-12/23
- 42134 Long-term Efficacy of Guselkumab (GUS) on Fatigue and Identification of Early Treatment Targets: Post Hoc Analysis Through 2 Years of a Phase 3, Randomized, Double-blind, Placebo-controlled Study in Biologic-naïve Patients With Psoriatic Arthritis (PsA)
- In situ detection of retinoid-X receptor expression in normal and psoriatic human skin
- In vivo response of GsdmA3Dfl/+ mice to topically applied anti-psoriatic agents: effects on epidermal thickness, as determined by optical coherence tomography and H&E staining
- Case Report of a Patient With Psoriasis Vulgaris, Psoriatic Arthritis and Alopecia Universalis Successfully Treated With Tofacitinib and Methotrexate
- Erythrodermic Psoriasis in the Context of Emerging Triggers: Insights into Dupilumab-Associated and COVID-19-Induced Psoriatic Disease
- 328 The transcription factor CEBPB is a novel hub gene and multi-functional disease driver in Psoriatic skin inflammation
- Extrarenal Expression of 25-Hydroxyvitamin D<sub>3</sub>-1α-Hydroxylase<sup>1</sup>
- Impact of Stat3 activation upon skin biology: A dichotomy of its role between homeostasis and diseases
- Type II Keratins Are Phosphorylated on a Unique Motif during Stress and Mitosis in Tissues and Cultured Cells
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- 17β-estradiol Inhibits the Production of RANTES in Human Keratinocytes
- Alopecia secondary to anti-tumor necrosis factor-alpha therapy
- Alopecia Areata following Adalimumab
- Efficacy of bergamot: From anti‐inflammatory and anti‐oxidative mechanisms to clinical applications as preventive agent for cardiovascular morbidity, skin diseases, and mood alterations
- CXCL12+ dermal fibroblasts promote neutrophil recruitment and host defense by recognition of IL-17
- Palmoplantar pustulosis–like eruption following tofacitinib therapy for juvenile idiopathic arthritis
- Antipsoriatic Activity of a New Synthetic Retinoid
- The Expression of Vitamin D-Upregulated Protein 1 in Skin and its Interaction with Sciellin in Cultured Keratinocytes
- Association between Alopecia Areata, Psoriasis Vulgaris, Thyroid Disease, and Metabolic Syndrome
- Histopathology of Scarring and Nonscarring Hair Loss
- Recovery of nail dystrophy potential new therapeutic indication of tofacitinib